Hansa Biopharma AB has appointed Maria Törnsén as Chief Operating Officer (COO) and President U.S., effective May 19. She will report to CEO Renée Aguiar-Lucander and be a member of the Executive Committee. Experience Törnsén has more than 20 years of experience across global and U.S. operations, where she held multiple senior commercial leadership roles. Most recently, she held the position of President North America at Calliditas Therapeutics, where she was responsible for the US comm...